Evaluating the efficacy of different doses of tocilizumab in treating critically ill COVID–19 patients: a single–center retrospective cohort study

ObjectivesTo evaluate the therapeutic efficacy of different doses of tocilizumab (TCZ) in patients with severe or critical COVID–19.MethodsIn this single–center retrospective cohort study conducted from January 2023 to January 2024, 56 hospitalized patients with severe or critical COVID–19 who recei...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Jie Gao, Wenjing Zhang, Yaru Ding, Xinru Peng, Jing Wang, Yuting Li, Jing Gao, Jie Cheng, Wei Zhou, Shuxiang Zhang
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-07-01
Serija:	Frontiers in Pharmacology
Teme:	COVID-19 SARS-CoV-2 tocilizumab IL-6 crp
Online dostop:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1571372/full
Oznake:	Označite Brez oznak, prvi označite!